Home 2018-09-27T10:20:09+00:00
test tube

KAHR is an Israeli biopharma company developing a unique oncology pipeline


Developing a novel drug platform of
bi-functional immunotherapeutic fusion proteins

test tubes

Diverse promising pipeline targeting
multiple cancer indications

KAHR’s Solution: Dual Signaling Proteins (DSPs)

Developing an innovative and novel drug platform of immunotherapeutic bi-functional fusion proteins that harness the human immune system to improve survival for cancer patients